Trince BV

Trince, a spin-off company from UGent is dedicated to delivering molecules into cells, both in vitro and ex vivo. It’s LumiPore transfection platform combines laser exposure and nanoparticles to transiently permeabilize cell membranes. It can be used to deliver a wide variety of effector molecules into virtually any cell type, including hard-to-transfect cells. The high-throughput technology ensures efficient and gentle transfection, maximizing the therapeutic quality of the final cell product.

Get in touch: